Recent advances in the molecular pathogenesis and targeted therapies of medullary thyroid carcinoma

Current Opinion in Oncology
Madson Q Almeida, Ana O Hoff

Abstract

This review will focus on the recent advances in molecular pathogenesis and targeted therapies for medullary thyroid carcinoma (MTC). Unlike hereditary MTC in which rearranged during transfection (RET) mutations are the most important precipitating events, in sporadic MTC the genetic or molecular biomarkers are yet to be established. Targeted molecular therapies that inhibit RET and other tyrosine kinase receptors involved in angiogenesis have shown great promise in the treatment of metastatic or locally advanced MTC and are under investigation. In addition, the recent findings of H-RAS mutations in 56% of RET-negative sporadic MTC and the activation of the mammalian target of rapamycin (mTOR) intracellular signaling pathway in hereditary MTC suggests that additional or alternative genetic events are important for MTC pathogenesis. Recently, vandetanib (ZD6474), an inhibitor of vascular endothelial growth factor receptor (VEGFR) 2 and VEGFR 3, RET, and epidermal growth factor receptor (EGFR), was approved for the treatment of adults with symptomatic or progressive MTC. Significant advantages for vandetanib over placebo were seen in terms of response rate, disease control rate, and biochemical response in a phase III study. Furt...Continue Reading

References

Aug 30, 1973·The New England Journal of Medicine·H J WolfeA H Tashjian
Feb 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·K M CarlsonH Donis-Keller
Jul 1, 1993·Human Molecular Genetics·H Donis-KellerS A Wells
Sep 7, 2001·Cytokine & Growth Factor Reviews·M Takahashi
Dec 12, 2001·The Journal of Clinical Endocrinology and Metabolism·M L BrandiS J Marx
Jan 1, 1959·The Journal of Clinical Endocrinology and Metabolism·J B HAZARDG CRILE
Dec 8, 2004·Cellular and Molecular Life Sciences : CMLS·M SantoroA Fusco
Jun 6, 2007·Hematology/oncology Clinics of North America·Ana O Hoff, Paulo M Hoff
Dec 13, 2007·The Journal of Clinical Endocrinology and Metabolism·Rossella EliseiAldo Pinchera
Feb 21, 2008·Clinical Endocrinology·Laura FugazzolaLuca Persani
Jun 11, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ezra E W CohenRoger B Cohen
Jul 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin J SchlumbergerSteven I Sherman
Jul 28, 2009·The Journal of Surgical Research·Anthony R HoganJuan E Sola
Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Samuel A Wells, Massimo Santoro
Jan 13, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Samuel A WellsMartin Schlumberger
Apr 7, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Elaine T LamManisha H Shah
Apr 8, 2010·The Journal of Clinical Endocrinology and Metabolism·Bruce G RobinsonRobert Haddad
Sep 18, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Laurie L CarrRenato G Martins
Oct 19, 2010·Cancer Genetics and Cytogenetics·Madson Q Almeida, Constantine A Stratakis
Oct 28, 2010·Human Mutation·Karin Frank-RaueUNKNOWN International RET Exon 10 Consortium
Feb 18, 2011·The Journal of Clinical Endocrinology and Metabolism·Margarida M MouraValeriano Leite
Apr 6, 2011·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Steven I Sherman
Apr 8, 2011·The Journal of Clinical Endocrinology and Metabolism·Hans H G VerbeekRobert M W Hofstra
May 6, 2011·The Journal of Clinical Endocrinology and Metabolism·Ida RapaMarco Volante
May 14, 2011·European Journal of Endocrinology·Merina AhmedChristopher M Nutting
May 25, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Razelle KurzrockRavi Salgia
May 31, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Deepak AbrahamStan B Sidhu
Jul 12, 2011·Biochemical Pharmacology·Valentina NicoliniCinzia Lanzi
Aug 25, 2011·Nature Reviews. Endocrinology·Steven G WaguespackGilbert J Cote
Oct 26, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Samuel A WellsMartin J Schlumberger
Dec 3, 2011·Science Translational Medicine·Sameek RoychowdhuryArul M Chinnaiyan

❮ Previous
Next ❯

Citations

Jul 9, 2013·International Journal of Clinical Oncology·Kalliopi Pazaitou-PanayiotouFrideriki Patakiouta
Apr 24, 2014·Thyroid : Official Journal of the American Thyroid Association·Veronika MancikovaMercedes Robledo
Dec 3, 2014·Clinics in Dermatology·Güliz İkizoğlu
Aug 29, 2014·European Journal of Endocrinology·Joana LyraPaula Soares
Jul 15, 2015·Expert Review of Anticancer Therapy·Silvia Martina FerrariPoupak Fallahi
May 27, 2014·The Surgical Clinics of North America·Uma RajhbeharrysinghMira Milas
Jun 18, 2015·Journal of Cellular and Molecular Medicine·Loris BertazzaCaterina Mian
Sep 4, 2015·Archives of Endocrinology and Metabolism·Ana O Hoff
Jan 29, 2014·Oncogene·N AkenoK A Wikenheiser-Brokamp
Mar 21, 2013·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Marcio L GriebelerGeoffrey B Thompson
Jul 23, 2013·The Oncologist·Gina M HowellLinwah Yip
Sep 17, 2013·The Oncologist·Madhuchhanda RoyRebecca S Sippel
Jun 4, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Bo ZhangYe Du
Dec 10, 2013·Advances in Anatomic Pathology·Marc P PusztaszeriWilliam C Faquin
Jan 26, 2017·The Journal of Biological Chemistry·Hai SongPao-Tien Chuang
Jun 29, 2017·Archives of Endocrinology and Metabolism·Léa Maria Zanini Maciel, Patrícia Künzle Ribeiro Magalhães

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Related Papers

Allergy and Asthma Proceedings
Karen Hsu Blatman, Anne Marie Ditto
Cancer Genetics and Cytogenetics
Madson Q Almeida, Constantine A Stratakis
Annals of Oncology : Official Journal of the European Society for Medical Oncology
P TomassettiR Corinaldesi
© 2022 Meta ULC. All rights reserved